{"result": "(\"entity\"<|>STAPHYLOCOCCUS<|>ORGANIZATION<|>Staphylococcus is a genus of bacteria, with S.epidermidis and S.aureus being the most common types associated with catheter infections.)\n##\n(\"entity\"<|>KLEBSIELLA<|>ORGANIZATION<|>Klebsiella is a type of gram-negative bacteria that can cause infections related to catheter use.)\n##\n(\"entity\"<|>CANDIDA ALBICANS<|>ORGANIZATION<|>Candida albicans is a fungus that can lead to infections, particularly in patients with catheters.)\n##\n(\"entity\"<|>BATERIEMIA 0<|>EVENT<|>Bacteriemia 0 is a hospital protocol aimed at preventing infections during catheter placement and manipulation.)\n##\n(\"entity\"<|>SYNDROME DE REALIMENTACION<|>EVENT<|>The syndrome of realimentation occurs in severely malnourished patients undergoing intensive nutritional replenishment, leading to various metabolic complications.)\n##\n(\"entity\"<|>INSULINA<|>ORGANIZATION<|>Insulin is a hormone used to manage blood glucose levels, especially in patients with hyperglycemia.)\n##\n(\"entity\"<|>GLUCOSA<|>ORGANIZATION<|>Glucose is a simple sugar that is a primary energy source for the body and is monitored in patients to manage hyperglycemia.)\n##\n(\"entity\"<|>GLUTAMINA<|>ORGANIZATION<|>Glutamine is an amino acid that can improve insulin sensitivity and reduce hospital complications when supplemented.)\n##\n(\"entity\"<|>CROMO<|>ORGANIZATION<|>Chromium is a micronutrient that may help improve glycemic control and insulin resistance in at-risk patients.)\n##\n(\"relationship\"<|>BATERIEMIA 0<|>STAPHYLOCOCCUS<|>The Bacteriemia 0 protocol aims to prevent infections caused by Staphylococcus during catheter procedures<|>7)\n##\n(\"relationship\"<|>BATERIEMIA 0<|>KLEBSIELLA<|>The Bacteriemia 0 protocol aims to prevent infections caused by Klebsiella during catheter procedures<|>7)\n##\n(\"relationship\"<|>BATERIEMIA 0<|>CANDIDA ALBICANS<|>The Bacteriemia 0 protocol aims to prevent infections caused by Candida albicans during catheter procedures<|>7)\n##\n(\"relationship\"<|>SYNDROME DE REALIMENTACION<|>GLUCOSA<|>The syndrome of realimentation is related to glucose management in malnourished patients<|>6)\n##\n(\"relationship\"<|>GLUCOSA<|>INSULINA<|>Insulin is administered to manage blood glucose levels, especially in cases of hyperglycemia<|>8)\n##\n(\"relationship\"<|>GLUTAMINA<|>INSULINA<|>Glutamine supplementation can enhance insulin sensitivity, aiding in better glucose control<|>6)\n##\n(\"relationship\"<|>CROMO<|>INSULINA<|>Chromium supplementation may improve insulin sensitivity and glycemic control in patients<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: trombosis en la luz del catéter o alrededor de éste, tanto en catéteres centrales como periféricos.\n\n- Infecciosas. Es la complicación más grave. Su incidencia varía según las series (alrededor de 5-8/1000pacientes/día). Se producen por la colonización del catéter y/o la piel del punto de inserción, siendo los microorganismos más frecuentes los Staphylococcus (sobretodo S.epidermidis y S.aureus) y bacterias gram-negativas (Klebsiella) y Candida albicans. El uso profiláctico de antibióticos previo a la colocación del catéter no disminuye el riesgo de infección. Por ello, para evitar las infecciones, se recomienda realizar medidas estrictas de asepsia en la colocación y manipulación del catéter (en el hospital está disponible el protocolo \"bacteriemia 0\").\n\n- Metabólicas. Son las más frecuentes:\n\n  · Alteraciones hidroelectrolíticas: tanto por exceso como por defecto. Para poder corregirlas es importante conocer las pérdidas que tiene el paciente (sondas, ostomías, vómitos,...). Dentro de ellas se encuentra el síndrome de realimentación, que se produce en pacientes muy desnutridos con escasa ingesta oral previa y en los que se realiza una reposición nutricional de forma intensiva. Se caracteriza por hipofosfatemia, hipopotasemia, hipomagnesemia y pudiéndose producir también retención de líquidos. Se evita realizando una restricción de volumen con disminución del aporte de glucosa, añadiendo tiamina (B1) al tratamiento y reemplazando los electrolitos que faltan.\n\n  · Hiperglucemia: es una complicación frecuente en pacientes sometidos a NP, especialmente en pacientes diabéticos. Se relaciona con un aumen-\n---\nto de las complicaciones infecciosas y de mortalidad. El aporte continuo de glucosa, bien sea enteral o parenteral, supone una mayor sobrecarga para la célula beta pancreática. Además la administración de dextrosa iv (se evita el efecto incretina) y el consumo muscular que ocurre en pacientes desnutridos en estado crítico y que lleva a una menor respuesta a la insulina en el músculo, conllevan a la aparición de una resistencia a la insulina. Esto, junto a la administración de dosis altas de corticoides y fármacos adrenérgicos, favorece la aparición de hiperglucemia de estrés en pacientes sin DM previa y la alteración del control metabólico del paciente diabético.\n\nAl ser la hiperglucemia un factor de mal pronóstico, es aconsejable monitorizar durante los primeros días los niveles de glucemia cada 4-6 horas para detectar precozmente cualquier elevación de los mismos. De esta forma se puede tratar precozmente y disminuir así los días de ingreso, el número de complicaciones y la mortalidad. En pacientes críticos se recomienda iniciar tratamiento con insulina cuando la cifra de glucemia supere los 150mg/dL\n\nPara afrontar esta hiperglucemia, además de la insulinización, se pueden realizar unas modificaciones en la NP:\n\n- Reducir el aporte de hidratos de carbono en la NP.\n\n- Reducir el aporte de lípidos en la NP, ya que los niveles elevados de ácidos grasos en el músculo conllevan una resistencia a la insulina.\n\n- Suplementación con glutamina: aumenta la secreción de insulina, mejora la sensibilidad del músculo estriado a la insulina, aumenta la oxidación de los ácidos grasos libres y disminuye la respuesta inflamatoria. Se asocia con una disminución de las complicaciones hospitalarias, acorta estancia en UCI y disminuye la mortalidad. Se recomienda suplementación precoz de glutamina en dosis mayores de 0,2g/kg/día para que sea efectiva.\n\n- En pacientes con déficit de cromo, la suplementación de este micronutriente podría mejorar el control glucémico y la resistencia a la insulina. Se administra a dosis de 20-40mcg/día, (dosis seguras hasta 200mcg). Se debería considerar la administración de cromo en pacientes con alto riesgo nutricional y con evidencia de resistencia a la insulina severa (con requerimientos elevados de insulina o con administración de glucosa por debajo de sus requerimientos).\n---\n· Hipoglucemia: debida a varias causas y es importante identificarlas para evitar futuros episodios; entre ellas: interrupción del soporte nutricional, resolución del estrés, disminución brusca de dosis de glucocorticoides o agentes simpaticomiméticos, disfunción renal, hepatitis grave, sepsis,....\n\nSiempre que sea posible utilizar la vía digestiva\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}